FDA Drug Application (202292) for FULYZAQ by NAPO PHARMS INC

Back to FDA Applications sponsored by NAPO PHARMS INC

Application Number202292
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameFULYZAQ
Active IngredientCROFELEMER



Back to FDA Applications sponsored by NAPO PHARMS INC